iifl-logo

Sun Pharmaceuticals Industries Ltd Historical Data

1,718.4
(-0.77%)
May 22, 2025|10:39:59 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Sun Pharmaceuticals Industries Ltd Historical Data

22/04/2025calendar-icon
22/05/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

22-Apr-2025

1,751

1,7551,734.51,747.451,0871,67,79,53,862.95,09,668

23-Apr-2025

1,754.2

1,791.31,742.11,788.860,5722,61,24,09,586.18,21,857

24-Apr-2025

1,790

1,807.91,773.91,803.982,9713,77,33,26,510.112,40,436

25-Apr-2025

1,806

1,815.51,764.21,787.488,9993,63,95,71,164.311,49,628

28-Apr-2025

1,787.4

1,8461,781.21,841.61,14,7015,88,64,25,863.223,48,194

29-Apr-2025

1,845

1,8461,7971,805.51,25,2955,24,22,46,980.619,01,355

30-Apr-2025

1,810

1,838.91,803.31,832.399,4194,88,15,71,584.917,02,688

02-May-2025

1,832.3

1,851.21,813.81,829.41,01,5794,22,99,82,09714,92,848

05-May-2025

1,827.8

1,843.31,821.41,836.665,0582,23,88,16,267.97,95,788

06-May-2025

1,820

1,827.91,7991,819.161,4182,57,05,45,159.68,48,747

07-May-2025

1,817.9

1,826.41,778.71,781.380,3433,60,78,04,178.112,47,576

08-May-2025

1,781.3

1,788.91,7551,767.21,13,6254,68,72,05,153.615,94,370

09-May-2025

1,751.9

1,766.31,731.71,744.872,9552,00,46,99,070.26,74,040

12-May-2025

1,695.7

1,712.41,623.61,686.22,78,21015,42,21,17,345.546,86,689

13-May-2025

1,711

1,748.51,691.31,7002,58,13511,92,53,08,73540,32,920

14-May-2025

1,702

1,711.41,692.11,708.282,2742,79,24,49,090.110,30,277

15-May-2025

1,701.1

1,744.41,684.11,740.11,46,8906,67,62,83,657.420,99,534

16-May-2025

1,740

1,741.61,7191,734.992,5932,50,85,37,705.67,85,798

19-May-2025

1,745

1,7651,726.61,730.21,05,2303,61,08,45,209.612,74,712

20-May-2025

1,743.8

1,7481,703.31,707.81,13,0194,64,52,60,502.919,33,363

21-May-2025

1,716.4

1,758.71,707.81,731.884,6404,78,59,60,056.213,07,555

Sun Pharma.Inds.: Related NEWS

Top Stocks for Today - 7th May 2025
7 May 2025|08:06 AM

NLC's subsidiary has executed a PPA with Rajasthan Rajya Vidyut Utpadan Nigam Ltd. (RVUNL) for 810 MW solar power plant at Pugal Solar Park, Rajasthan

Read More
Sun Pharma’s MM-II Trial Shows Long-Lasting Relief for Knee Osteoarthritis
26 Apr 2025|01:15 PM

Based on the Phase 2b clinical trial, the study used a randomised, double-blind, placebo-controlled design that yielded strong and dependable data.

Read More
Sun Pharma to Acquire Nasdaq-Listed Checkpoint Therapeutics for $355 Million
10 Mar 2025|10:46 AM

The deal is expected to be completed in the second quarter of 2025, subject to customary closing conditions and regulatory approvals.

Read More
Sun Pharma Q3 Profit Jumps 19% YoY, Declares ₹10.50 Dividend
31 Jan 2025|10:17 PM

An interim dividend of ₹10.50 on the face value per share for FY25 has been declared.

Read More
Sun Pharma reports Q2 net profit at ₹3,040 Crore
29 Oct 2024|10:30 AM

Sun Pharma has bolstered its speciality pipeline with a partnership with Philogen to commercialise late-stage candidate Fibromun.

Read More
Sun Pharma's Hair Loss Drug Approved by USFDA
26 Jul 2024|01:45 PM

The US Food and Drug Administration (USFDA) has approved LEQSELVI (deuruxolitinib) 8 mg tablets, according to a regulatory filing.

Read More
Mayne Pharma Sues Sun Pharma in Patent Dispute
25 Jul 2024|11:57 AM

IMVEXXY is a vaginal insert designed to lessen pain during sexual activity after menopause which is manufactured by Mayne Pharma.

Read More
USFDA grills Sun Pharma for manufacturing issues at Dadra facility
4 Jul 2024|11:24 AM

The warning letter detailed substantial violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals at the facility.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.